Preserving U.S. innovation worldwide is more important than ever

The COVID-19 pandemic has spurredunprecedented levels of innovation within the biopharmaceutical industry to combat this urgent global health crisis. PhRMA member companies are collaborating with governments, academia, NGOs and one another and areworking around the clock to research, develop and deliverCOVID-19 vaccines and treatments. This swift action and collaboration is made possible because the United States protects and values innovation – which helped enable our industry to translate research into safe and effective products in less than a year that can end the pandemic.
Source: The Catalyst - Category: Pharmaceuticals Authors: Tags: Economic Impact Intellectual Property Trade Source Type: news